4MANCIA G,DE BACKER G,DOMINICZAK A,et al.2007 Guidelines for the managemant of arterial hypertension[J].Eur Heart J,2007,28(12):1 462-1 536.
5AUSTEN W G,EDWARDS J E,FRYE R L,et al.A reporting system on patients evaluated for coronary artery disease.Report of the Ad Hoc Committee for Grading of Coronary Artery Disease,Council on Cardiovascular Surgery[J].American Heart Association Circulation,1975,51 (4 Supp 1):5 -40.
6GENSINI G G.A more meaningful scoring system for determining the severity of corouary heart disease[J].Am J Cardiol,1983,51 (3):606-607.
7CARR M C,BRUNZELL J D.Abdominal obesity and dyslipidemia in the metabolic syndrome:Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk[J].J Clin Endocrinol Metah,2004,89:2 601-2 607.
8DAS B,DAGA M K,GUPTA S K.Lipid Pentad Index:A novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India[J].Clin Biochem,2007,40(1-2):18-24.
9ENAS E A,MOHAN V,DEEPA M,et al.The metabolic syndrome and dyslipidemia among Asian Indians:u population with high rates of diabetes and premature coronary artery disease[J].J Cardiometab Syndr,2007,2 (4):267-275.
10GEORGIEVA A M,CATE H T,KEULEN E T,et al.Prothrombotic markers in familial combined hyperlipidemia:Evidence of endothelial cell activation and relation to metabolic syndrome[J].Atherosclerosis,2004,175(2):345-351.
